Michael Boyiadzis – författare

A top-to-bottom overview of cancer immunotherapy–from basic science to clinical application

The rapidly evolving field of immunotherapy is thoroughly and expertly covered in this cutting-edge text. Written by a world-renowned author team, this innovative resource provides readers with a solid grasp of the fundamental principles of basic immunology so they can better understand the medical uses of immunotherapy. The book then advances to practical application and toxicity management. Presented in a concise, templated, and easy-to-read format, Cancer Immunotherapy in Clinical Practice is the single-best resource for readers to familiarize themselves with the medical use of immunotherapy. The book includes an entire section on eighteen individual cancer types (brain, breast, etc.) with listings of approved drugs, information on each drug, and discussion of emerging therapies for each of the cancers.

Groundbreaking in that it is the first cancer immunology book to combine the basic science with actual clinical applicationIncludes the latest guidelines for immunotherapy, cancer immunotherapy, and toxicity managementValuable opening section includes discussion of introduction to immunotherapy, components of the immune system, vaccines, the immune system in cancer, and more

The essential therapy guide to cancer, hematologic disorders, and supportive care—updated with the latest treatment regimens

A Doody's Core Title for 2022, 2023, 2024 & 2026!

Hematology-Oncology Therapy, Third Edition, is an up-to-date, comprehensive therapy guide that delivers more than 800 treatment regimens in a succinct, uniform format.  Supported by the latest practice guidelines, peer-reviewed literature, and insights from experts in the field, this peerless resource integrates extensive information critical to both office- and hospital-based practice of hematology and oncology.

Hematology-Oncology Therapy is divided into four sections:

Cancer Regimens: Covers administration, toxicity, dose modification, monitoring, supportive care, and the efficacy of commonly used and recently approved therapeutic regimens, and includes expert opinion and critical information on epidemiology, pathology, work-up, and staging, as well as survival dataAntiemetics, Growth Factors, Dose Modification and Drug Preparation: Provides in-depth coverage of antiemetics, growth factors, and the administration and formulation of anti-cancer drugsSupportive Care, Complications, and Screening (online): Offers thorough coverage of topics commonly encountered in clinical hematology-oncology practiceSelected Hematologic Diseases (online): provides an authoritative guide to therapy for principal diseases in consultative hematology

The entire content is now online at AccessHemOnc.com. The online platform created for the third edition will be continually updated, including newly approved regimens.